Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

In patients with unilateral pleural effusion, restricted lung inflation is the principal predictor of increased dyspnoea.

Garske LA, Kunarajah K, Zimmerman PV, Adams L, Stewart IB.

PLoS One. 2018 Oct 3;13(10):e0202621. doi: 10.1371/journal.pone.0202621. eCollection 2018.

2.

Screen-detected subsolid pulmonary nodules: long-term follow-up and application of the PanCan lung cancer risk prediction model.

Zhao H, Marshall HM, Yang IA, Bowman RV, Ayres J, Crossin J, Lau M, Slaughter RE, Redmond S, Passmore L, McCaul E, Courtney D, Leong SC, Windsor M, Zimmerman PV, Fong KM.

Br J Radiol. 2016;89(1060):20160016. doi: 10.1259/bjr.20160016. Epub 2016 Feb 16.

3.

Lung cancer screening feasibility in Australia.

Marshall HM, Bowman RV, Ayres J, Crossin J, Lau M, Slaughter RE, Redmond S, Passmore L, McCaul E, Courtney D, Leong SC, Windsor M, Zimmerman PV, Yang IA, Fong KM.

Eur Respir J. 2015 Jun;45(6):1734-7. doi: 10.1183/09031936.00208714. Epub 2015 Apr 2. No abstract available.

4.

Exhaled breath analysis for lung cancer.

Dent AG, Sutedja TG, Zimmerman PV.

J Thorac Dis. 2013 Oct;5 Suppl 5:S540-50. doi: 10.3978/j.issn.2072-1439.2013.08.44. Review.

5.

Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD).

Shaw JG, Dent AG, Passmore LH, Burstow DJ, Bowman RV, Zimmerman PV, Fong KM, Yang IA.

BMC Pulm Med. 2012 Jun 13;12:25. doi: 10.1186/1471-2466-12-25.

6.

Queensland Lung Cancer Screening Study: rationale, design and methods.

Marshall HM, Bowman RV, Crossin J, Lau MA, Slaughter RE, Passmore LH, McCaul EM, Courtney DA, Windsor MN, Yang IA, Smith IR, Keir BJ, Hayes TJ, Redmond SJ, Zimmerman PV, Fong KM.

Intern Med J. 2013 Feb;43(2):174-82. doi: 10.1111/j.1445-5994.2012.02789.x.

PMID:
22471951
7.

Variability in the rate of prescription and cost of domiciliary oxygen therapy in Australia.

Serginson JG, Yang IA, Armstrong JG, Cooper DM, Matthiesson AM, Morrison SC, Gair JM, Cooper B, Zimmerman PV.

Med J Aust. 2009 Nov 16;191(10):549-53.

PMID:
19912087
8.

Exploratory study of the 'weekend effect' for acute medical admissions to public hospitals in Queensland, Australia.

Clarke MS, Wills RA, Bowman RV, Zimmerman PV, Fong KM, Coory MD, Yang IA.

Intern Med J. 2010 Nov;40(11):777-83. doi: 10.1111/j.1445-5994.2009.02067.x.

PMID:
19811554
9.

Genetic susceptibility to the respiratory effects of air pollution.

Yang IA, Fong KM, Zimmerman PV, Holgate ST, Holloway JW.

Postgrad Med J. 2009 Aug;85(1006):428-36. doi: 10.1136/thx.2007.079426.

PMID:
19633009
10.

Genetic susceptibility to the respiratory effects of air pollution.

Yang IA, Fong KM, Zimmerman PV, Holgate ST, Holloway JW.

Thorax. 2008 Jun;63(6):555-63. doi: 10.1136/thx.2007.079426. Review.

PMID:
18511640
11.

Quantified tracheobronchomalacia disorders and their clinical profiles in children.

Masters IB, Zimmerman PV, Pandeya N, Petsky HL, Wilson SB, Chang AB.

Chest. 2008 Feb;133(2):461-7. Epub 2007 Nov 7.

PMID:
17989148
12.

Longitudinal quantification of growth and changes in primary tracheobronchomalacia sites in children.

Masters IB, Zimmerman PV, Chang AB.

Pediatr Pulmonol. 2007 Oct;42(10):906-13.

PMID:
17708575
13.
14.

Airway sizes and proportions in children quantified by a video-bronchoscopic technique.

Masters IB, Ware RS, Zimmerman PV, Lovell B, Wootton R, Francis PV, Chang AB.

BMC Pulm Med. 2006 Mar 8;6:5.

15.

Respiratory function tests and their application.

Pierce RJ, Hillman D, Young IH, O'Donoghue F, Zimmerman PV, West S, Burdon JG.

Respirology. 2005 Nov;10 Suppl 2:S1-19. No abstract available.

PMID:
16255724
16.

CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.

Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM.

Carcinogenesis. 2006 Mar;27(3):525-32. Epub 2005 Sep 29.

PMID:
16195240
17.

A new method for objective identification and measurement of airway lumen in paediatric flexible videobronchoscopy.

Masters IB, Eastburn MM, Wootton R, Ware RS, Francis PW, Zimmerman PV, Chang AB.

Thorax. 2005 Aug;60(8):652-8.

18.

Effectiveness of hospital-based smoking cessation.

Fung PR, Snape-Jenkinson SL, Godfrey MT, Love KW, Zimmerman PV, Yang IA, Fong KM.

Chest. 2005 Jul;128(1):216-23.

PMID:
16002938
19.

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.

Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM.

Cancer Causes Control. 2005 Jun;16(5):579-85.

PMID:
15986113
20.

Cochrane systematic reviews of treatments for lung cancer.

Fong KM, Yang IA, Zimmerman PV, Bowman RV.

Respir Med. 2005 Sep;99(9):1071-8. Review.

21.

Quantification of the magnification and distortion effects of a pediatric flexible video-bronchoscope.

Masters IB, Eastburn MM, Francis PW, Wootton R, Zimmerman PV, Ware RS, Chang AB.

Respir Res. 2005 Feb 10;6:16.

22.

Cytokine gene polymorphisms in idiopathic pulmonary fibrosis.

Riha RL, Yang IA, Rabnott GC, Tunnicliffe AM, Fong KM, Zimmerman PV.

Intern Med J. 2004 Mar;34(3):126-9.

PMID:
15030461
23.

Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections.

Yang IA, Seeney SL, Wolter JM, Anders EM, McCormack JG, Tunnicliffe AM, Rabnott GC, Shaw JG, Dent AG, Kim ST, Zimmerman PV, Fong KM.

Genes Immun. 2003 Jun;4(4):269-74.

PMID:
12761563
24.

Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia.

Riha RL, Duhig EE, Clarke BE, Steele RH, Slaughter RE, Zimmerman PV.

Eur Respir J. 2002 Jun;19(6):1114-8.

25.

The decline in hospital autopsy rates in 2001.

Ward HE, Clarke BE, Zimmerman PV, Cleary MI.

Med J Aust. 2002 Jan 21;176(2):91. No abstract available.

PMID:
11936301
26.
27.

Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicity.

Devine PL, Siebert WJ, Morton SL, Scells B, Quin RJ, Heddle WF, Zimmerman PV, Donohoe PJ.

Dis Markers. 1998 Nov;14(3):169-75.

29.

KRAS codon 12 mutations in Australian non-small cell lung cancer.

Fong KM, Zimmerman PV, Smith PJ.

Aust N Z J Med. 1998 Apr;28(2):184-9.

PMID:
9612526
30.

Association of chromosome 11 locus D11S12 with histology, stage, and metastases in lung cancer.

Bepler G, Fong KM, Johnson BE, O'Briant KC, Daly LA, Zimmerman PV, Garcia-Blanco MA, Peterson B.

Cancer Detect Prev. 1998;22(1):14-9.

PMID:
9466044
31.

Lung cancer.

Sellars RE, Zimmerman PV.

Med J Aust. 1997 Jul 21;167(2):99-104. Review.

PMID:
9251697
32.

The Australian National Asthma Campaign: effects of public education activities based on mass media.

Comino EJ, Bauman A, Mitchell CA, Ruffin RE, Antic R, Zimmerman PV, Gutch RC.

Am J Prev Med. 1997 Jul-Aug;13(4):251-6.

PMID:
9236960
33.

FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.

Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.

Cancer Res. 1997 Jun 1;57(11):2256-67.

34.

Gorham's syndrome: a usually fatal cause of pleural effusion treated successfully with radiotherapy.

McNeil KD, Fong KM, Walker QJ, Jessup P, Zimmerman PV.

Thorax. 1996 Dec;51(12):1275-6.

35.

MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.

Fong KM, Kida Y, Zimmerman PV, Smith PJ.

Br J Cancer. 1996 Dec;74(12):1975-8.

36.

TIMP1 and adverse prognosis in non-small cell lung cancer.

Fong KM, Kida Y, Zimmerman PV, Smith PJ.

Clin Cancer Res. 1996 Aug;2(8):1369-72.

37.

Lung pathology: the molecular genetics of non-small cell lung cancer.

Fong KM, Zimmerman PV, Smith PJ.

Pathology. 1995 Oct;27(4):295-301. Review.

PMID:
8771143
38.

Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer.

Fong KM, Kida Y, Zimmerman PV, Ikenaga M, Smith PJ.

Cancer Res. 1995 Oct 1;55(19):4268-72.

39.

Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction.

Fong KM, Schonrock J, Frazer IM, Zimmerman PV, Smith PJ.

Cancer. 1995 May 1;75(9):2400-1. No abstract available.

PMID:
7712451
40.

Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer.

Fong KM, Zimmerman PV, Smith PJ.

Cancer Res. 1995 Jan 15;55(2):220-3.

41.

Microsatellite instability and other molecular abnormalities in non-small cell lung cancer.

Fong KM, Zimmerman PV, Smith PJ.

Cancer Res. 1995 Jan 1;55(1):28-30.

42.

Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer.

Fong KM, Zimmerman PV, Smith PJ.

Genes Chromosomes Cancer. 1994 Jul;10(3):183-9.

PMID:
7522041
43.

Amiodarone pulmonary toxicity--three unusual manifestations.

McNeil KD, Firouz-Abadi A, Oliver W, Zimmerman PV.

Aust N Z J Med. 1992 Feb;22(1):14-8.

PMID:
1580855
44.

Primary lung cancer: characterization and survival of 1024 patients treated in a single institution.

Hawson G, Zimmerman PV, Ford CA, Johnston NG, Firouz-Abadi A.

Med J Aust. 1990 Mar 5;152(5):230-4.

PMID:
2175011
45.

Ploidy as a prognostic determinant in surgically treated lung cancer.

Zimmerman PV, Hawson GA, Bint MH, Parsons PG.

Lancet. 1987 Sep 5;2(8558):530-3.

PMID:
2887832
46.

The effect of inspiratory resistive training on exercise capacity in optimally treated patients with severe chronic airflow limitation.

McKeon JL, Turner J, Kelly C, Dent A, Zimmerman PV.

Aust N Z J Med. 1986 Oct;16(5):648-52.

PMID:
3469962
47.

Intrapulmonary coin lesions: the changing patterns.

Francis DB, Zimmerman PV.

Med J Aust. 1986 Feb 3;144(3):122-3.

PMID:
3945200
48.

Pulmonary dirofilariasis diagnosed by computerised tomography scan controlled percutaneous needle aspiration.

Kelly WT, Firouz-Abadi AA, Roszkowski A, Zimmerman PV.

Aust N Z J Med. 1985 Oct;15(5):656-7.

PMID:
3867345
49.

Hydrocortisone-induced anaphylaxis.

Chan CS, Brown IG, Oliver WA, Zimmerman PV.

Med J Aust. 1984 Sep 29;141(7):444-6.

PMID:
6472184
50.

Supplemental Content

Loading ...
Support Center